Industry: Medical Devices
EVOLENCE injectable filler, developed by ColBar LifeScience Ltd., utilizes the GLYMATRIX technology to create a professionally administered, injectable treatment for soft tissue deficiencies, especially facial wrinkles. In 2006 EVOLENCE was purchased by Johnson & Johnson, and gained FDA approval in 2007.
Despite the fierce competition in the aesthetic medicine field, EVOLENCE has managed to establish a significant position among its adversaries, and has become a necessary part of the aesthetic clinic portfolio.
Global marketing plan
Naming and brand positioning
Training and education
Advisory board management
Exhibitions and industry events
Wolff Olins branding
Jason&Jason Visual Communications
Miri Davidovitz photography
Tal Arazi Visual Communications
YKM web design